TR200201322T2 - H1 antagonistleri ve güvenli bir steroid'in göz sağlık koşullarının tedavisi için kullanımı - Google Patents

H1 antagonistleri ve güvenli bir steroid'in göz sağlık koşullarının tedavisi için kullanımı

Info

Publication number
TR200201322T2
TR200201322T2 TR2002/01322T TR200201322T TR200201322T2 TR 200201322 T2 TR200201322 T2 TR 200201322T2 TR 2002/01322 T TR2002/01322 T TR 2002/01322T TR 200201322 T TR200201322 T TR 200201322T TR 200201322 T2 TR200201322 T2 TR 200201322T2
Authority
TR
Turkey
Prior art keywords
antagonists
treatment
health conditions
eye health
safe steroid
Prior art date
Application number
TR2002/01322T
Other languages
English (en)
Inventor
M. Yanni John
Original Assignee
Alcon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon, Inc. filed Critical Alcon, Inc.
Publication of TR200201322T2 publication Critical patent/TR200201322T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Abstract

H1 antagonistleri ve oküler olarak güvenli steroidler ile VKC, GPC, ve AKC tedavisi için bilesimler ve yöntemler ifsa edilmistir.
TR2002/01322T 1999-11-18 2000-10-26 H1 antagonistleri ve güvenli bir steroid'in göz sağlık koşullarının tedavisi için kullanımı TR200201322T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16619499P 1999-11-18 1999-11-18

Publications (1)

Publication Number Publication Date
TR200201322T2 true TR200201322T2 (tr) 2002-11-21

Family

ID=22602196

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01322T TR200201322T2 (tr) 1999-11-18 2000-10-26 H1 antagonistleri ve güvenli bir steroid'in göz sağlık koşullarının tedavisi için kullanımı

Country Status (12)

Country Link
US (1) US6649602B1 (tr)
EP (1) EP1242090A4 (tr)
CN (1) CN1376066A (tr)
AU (1) AU772406B2 (tr)
BR (1) BR0015647A (tr)
CA (1) CA2380532A1 (tr)
HK (1) HK1047699A1 (tr)
MX (1) MXPA02005007A (tr)
PL (1) PL355101A1 (tr)
TR (1) TR200201322T2 (tr)
WO (1) WO2001035963A1 (tr)
ZA (1) ZA200201903B (tr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
TWI231759B (en) 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
DK1467762T3 (da) * 2001-12-05 2006-04-10 Alcon Inc Anvendelse af en H1-antagonist og rimexolon som et sikkert steroid til behandling af rhinitis
CA2495830C (en) 2002-08-30 2012-08-21 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
CA2504200A1 (en) * 2002-11-12 2004-05-27 Alcon, Inc. The use of an anti-allergy agent and a steroid to treat allergic rhinitis
US20060036220A1 (en) * 2003-01-22 2006-02-16 Kohji Kawahara Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye
US20050239745A1 (en) * 2004-03-03 2005-10-27 Ophthalmic Research Associates, Inc. Novel topical ophthalmic formulations
CA2585266C (en) * 2004-10-25 2010-10-19 Bausch & Lomb Incorporated Ophthalmic compositions and methods of using the same
US20060089384A1 (en) * 2004-10-25 2006-04-27 Minno George E Ophthalmic compositions and methods of using the same
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
DK2522365T3 (en) 2004-11-24 2017-02-06 Meda Pharmaceuticals Inc Compositions comprising azelastine and methods for its use
WO2006097458A1 (en) * 2005-03-15 2006-09-21 Nycomed Gmbh Novel combination
BRPI0716625A2 (pt) * 2006-09-11 2013-10-08 Bausch & Lomb Composição, e, uso de um agonista de receptor de glicocorticóide dissociado e um medicamento antialérgico.
US20110104159A1 (en) * 2006-09-11 2011-05-05 Rohrs Brian R Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
US20110105559A1 (en) * 2006-09-11 2011-05-05 Rohrs Brian R Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy
EP2222299B1 (en) * 2007-11-19 2011-11-23 Bausch & Lomb Incorporated Use of levocabastine for modulating generation of pro-inflammatory cytokines
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
EP2408453B1 (en) 2009-03-17 2022-01-05 Nicox Ophthalmics, Inc. Ophthalmic formulations of cetirizine and methods of use
JP2012520880A (ja) * 2009-03-17 2012-09-10 アーシエックス セラピューティックス， インコーポレイテッド ケトチフェンの眼科用製剤および使用方法
US20130023520A1 (en) * 2011-07-24 2013-01-24 Amir Sahba Jalali Anaesthetic eye solution and method of use
WO2013061269A1 (en) * 2011-10-26 2013-05-02 Micro Labs Limited Combinations of loteprednol and olopatadine for the treatment of ocular allergies
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223493A (en) 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US5149694A (en) 1988-03-09 1992-09-22 Alcon Laboratories, Inc. Combination of tobramycin and dexamethasone for topical ophthalmic use
US5192780A (en) 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
US5668133A (en) * 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
US5420120A (en) 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use

Also Published As

Publication number Publication date
AU4610101A (en) 2001-05-30
HK1047699A1 (zh) 2003-03-07
EP1242090A4 (en) 2004-02-11
EP1242090A1 (en) 2002-09-25
WO2001035963A1 (en) 2001-05-25
MXPA02005007A (es) 2004-08-12
PL355101A1 (en) 2004-04-05
AU772406B2 (en) 2004-04-29
US6649602B1 (en) 2003-11-18
ZA200201903B (en) 2003-05-28
CA2380532A1 (en) 2001-05-25
BR0015647A (pt) 2002-07-16
CN1376066A (zh) 2002-10-23

Similar Documents

Publication Publication Date Title
TR200201322T2 (tr) H1 antagonistleri ve güvenli bir steroid'in göz sağlık koşullarının tedavisi için kullanımı
IL143901A0 (en) Use of cyclooxygenase-2- inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
DE60041917D1 (de) ehandlung von stressbedingter Harninkontinenz
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
MXPA03005893A (es) Proteccion, restauracion, y mejora de celulas, tejidos y organos que responden a la eritropoyetina.
NZ508808A (en) 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists
SG170612A1 (en) Antineoplastic combinations
EE05003B1 (et) Dihdro-1,3,5-triasiinamino derivaadid ja nende kasutamine ravis
ATE103918T1 (de) 5,11-dihydro-6h-dipyrido(3,2-b:2',3'e>(1,4>diazepin-6-one und -thione und ihre verwendung bei der aids-vorbeugung oder behandlung.
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
EP1383529A4 (en) METHOD FOR THE TREATMENT OF EYES AND SQUATING TISSUES WITH THYMOSINE 4 (T 4), ANALOGUE, ISOFORMS AND OTHER DERIVATIVES
DK1187611T3 (da) Oftalmiske histaminholdige sammensætninger og anvendelse deraf
NO984572L (no) Anvendelse av 2,5-dihydroksybenzensulfonderivater for fremstilling av legemidler ment for normalisering av den endoteliale funksjon, for behandling av seksuell dysfunksjon og vaskulµre komplikasjoner i diabetes, sÕvel som vaskulµre lidelser av e
TR200302008T4 (tr) Dış retina bozukluklarının tedavisine yönelik bir ilaç üretiminde beta-adrenoseptör antagonistlerin kullanımı.
DE60032459D1 (de) Behandlung von restenose und atherosklerose mit einem löslichen vegf rezeptor und angiopoietin-1
TR200002939T2 (tr) Paroksetin maleat
NO20030985L (no) Behandling av betennelsestilstander
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
IL143280A0 (en) Use of riluzole for treating acoustic traumas
NZ501366A (en) Use of low-molecular-weight heparins for the prevention and treatment of cerebral oedemas
DE69827017D1 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
MXPA03004074A (es) Derivados de retiferol y su uso en el tratamiento de enfermedades o trastornos de la piel asociadas con fotoda°o.